Integrated Chemical Profiling, Network Pharmacology, and Zebrafish/Cellular Models Identify Potential Anti-Osteoporotic Constituents of Cynomorium songaricum Rupr.
Open Access
- 30 October 2026
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1137
Abstract
Cynomorium songaricum Rupr. (CSR) is extensively utilized in traditional Chinese medicine for the treatment of bone disorders; however, its bioactive components and underlying mechanisms remain inadequately characterized. This study investigated the potential anti-osteoporotic constituents and mechanisms of CSR by integrating UPLC-Q-TOF-MS/MS, zebrafish and MC3T3-E1 cellular models, network pharmacology, molecular dynamics (MD) simulations, and RT-qPCR validation. Phenotypic evaluations showed that CSR aqueous extract significantly mitigated vertebral bone mineralization loss in glucocorticoid-induced zebrafish, while promoting cell proliferation and ALP activity in dexamethasone-treated MC3T3-E1 osteoblasts. Chemical profiling identified 21 components in the extract. Five candidate active ingredients and key targets were screened via network pharmacology, with predicted enrichment in the HIF-1 and VEGF signaling pathways. Molecular docking and 100 ns MD simulations predicted favorable binding poses and conformational stability between candidate compounds and core targets. Furthermore, maslinic acid, a candidate bioactive triterpenoid, improved cellular readouts under glucocorticoid challenge and was associated with reduced Casp3 mRNA and increased Runx2, Vegfa, and Mapk3 mRNA. These findings provide valuable insights into the multi-component osteoprotective potential of CSR, providing a solid scientific foundation for its future mechanistic exploration and therapeutic development.Keywords
Funding Information
- Jilin Provincial Key Research and Development Plan Project (20250601013RC)
- Pilot Selection Projects of Universities and Research Institutes in Changchun (24GXYSZZ12)
This publication has 43 references indexed in Scilit:
- Osteoporosis: Emerging targets on the classical signaling pathways of bone formationEuropean Journal of Pharmacology, 2024
- Exploring epigenetic strategies for the treatment of osteoporosisMolecular Biology Reports, 2024
- Structures and neuroprotective activities of triterpenoids from Cynomorium coccineum subsp. songaricum (Rupr.) J. LeonardPhytochemistry, 2022
- Lipidomics characterization of the mechanism of Cynomorium songaricum polysaccharide on treating type 2 diabetesJournal of Chromatography B, 2021
- Anti-osteoporotic effects of syringic acid and vanilic acid in the extracts of waste beds after mushroom cultivationJournal of Bioscience and Bioengineering, 2019
- Hormesis: A Compelling Platform for Sophisticated Plant ScienceTrends in Plant Science, 2019
- Cynomorium songaricum prevents bone resorption in ovariectomized rats through RANKL/RANK/TRAF6 mediated suppression of PI3K/AKT and NF-κB pathwaysLife Sciences, 2018
- Sex hormone levels as determinants of bone mineral density and osteoporosis in Vietnamese women and menJournal of Bone and Mineral Metabolism, 2014
- Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathwaysJournal of Bone and Mineral Research, 2010
- Structural Basis of the Drug-binding Specificity of Human Serum AlbuminJournal of Molecular Biology, 2005